Home Formation Bio

Formation Bio

In operation
Series D
Biotechnology Platform Provider
Basic
Enterprise Profile

Basic Information

Formation Bio aims to bring treatments to patients by reimagining drug development. The company’s platform has expanded a network of trial sites, utilizing a roaming cohort of certified research coordinators optimized through software, data, and technology, creating clinical trial sites within existing practices. This allows researchers to broaden access to human subjects for conducting studies, paid clinical trials, psychological research, and focus groups.
Formation Bio, Inc.
NewYork,NewYork,United States of America
101~500 people
June 01, 2014
--

Enterprise Profile

Industrial Sector
Drug-Related New Drug Development CRO
Technology
Artificial Intelligence
Application Scenarios
AI+Pharmaceuticals